Personensuche
Personensuche
Es wurde 1 Person gefunden.
Aktuelle Veranstaltungen
-
WiSe 2025
Vergangene Veranstaltungen (max. 10)
-
SoSe 2025
-
WiSe 2024
-
SoSe 2024
-
WiSe 2023
-
SoSe 2023
-
WiSe 2022
-
SoSe 2022
-
WiSe 2021
-
SoSe 2021
-
WiSe 2020
Die folgenden Publikationen sind in der Online-Universitätsbibliographie der Universität Duisburg-Essen verzeichnet. Weitere Informationen finden Sie gegebenenfalls auch auf den persönlichen Webseiten der Person.
-
Prognostic factors in nonsmall cell lung cancer : insights from the German CRISP registryIn: European Respiratory Journal (ERJ), Jg. 61, 2023, Nr. 2, 2201336DOI (Open Access)
-
Genetic Variants of the NKG2C/HLA-E Receptor : Ligand Axis Are Determinants of Progression-Free Survival and Therapy Outcome in Aggressive B-Cell LymphomaIn: Cancers, Jg. 12, 2020, Nr. 11, S. 3429DOI, Online Volltext (Open Access)
-
Six versus eight doses of rituximab in patients with aggressive B cell lymphoma receiving six cycles of CHOP : results from the “Positron Emission Tomography-Guided Therapy of Aggressive Non-Hodgkin Lymphomas” (PETAL) trialIn: Annals of Hematology, Jg. 98, 2019, Nr. 4, S. 897 – 907
-
HLA-E allelic genotype correlates with HLA-E plasma levels and predicts early progression in chronic lymphocytic leukemiaIn: Cancer, Jg. 123, 2017, Nr. 5, S. 814 – 823
-
Shorter telomeres correlate with an increase in the number of uniparental disomies in patients with chronic lymphocytic leukemiaIn: Leukemia and Lymphoma, Jg. 57, 2016, Nr. 3, S. 590 – 595
-
Elevated levels of soluble HLA-E and the presence of HLA-E*01:03 predict disease of progression in CLLIn: Tissue Antigens, Jg. 86, 2015, Nr. 2, S. 85 – 86
-
Soluble HLA-E and HLA-E polymorphism predictors of early disease progression in CLLIn: Tissue Antigens, Jg. 85, 2015, Nr. 5, S. 327 – 328
-
CD49d is the strongest flow cytometry-based predictor of overall survival in chronic lymphocytic leukemiaIn: Journal of Clinical Oncology (JCO), Jg. 32, 2014, Nr. 9, S. 897 – 904DOI, Online Volltext (Open Access)
-
MDM2 promotor polymorphism and disease characteristics in chronic lymphocytic leukemia : results of an individual patient data-based meta-analysisIn: Haematologica / The Hematology Journal, Jg. 99, 2014, Nr. 8, S. 1285 – 1291DOI (Open Access)
-
Incidence of therapy-related acute leukaemia in mitoxantrone-treated multiple sclerosis patients in GermanyIn: Therapeutic Advances in Neurological Disorders, Jg. 5, 2012, Nr. 2, S. 75 – 79DOI, Online Volltext (Open Access)
-
Prognostic significance of serum cystatin C in multiple myelomaIn: International Journal of Hematology, Jg. 95, 2012, Nr. 5, S. 545 – 550
-
Significance of chromosomal aberrations and HMGA2 expression in Paroxysmal Nocturnal Hemoglobinuria (PNH)In: Onkologie, Jg. 35, 2012, Nr. Suppl. 6, S. 220 – 221
-
p53 protein expression in chronic lymphocytic leukemiaIn: Leukemia and Lymphoma, Jg. 53, 2012, Nr. 7, S. 1282 – 1288
-
Association of soluble MICA levels to the MICA-129 polymorphism and treatment free survival in chronic lymphocytic leukaemia patientsIn: Tissue Antigens, Jg. 77, 2011, Nr. 5, S. 393 – 393
-
Association of the CC genotype of the regulatory BCL2 promoter polymorphism (−938C>A) with better 2-year survival in patients with glioblastoma multiformeIn: Journal of Neurosurgery (JNS), Jg. 114, 2011, Nr. 6, S. 1631 – 1639
-
Excessive bilirubin elevation in a patient with hereditary spherocytosis and intrahepatic cholestasisIn: Zeitschrift für Gastroenterologie, Jg. 49, 2011, Nr. 8, S. 977 – 980
-
Investigating the role of CD38 and functionally related molecular risk factors in the CLL NOD/SCID xenograft modelIn: European Journal of Haematology, Jg. 87, 2011, Nr. 1, S. 10 – 19
-
Maligne epibulbäre Tumoren : Neue Strategien in Diagnostik und TherapieIn: Klinische Monatsblätter für Augenheilkunde, Jg. 228, 2011, Nr. 9, S. 780 – 792
-
Regulatory BCL2 promoter polymorphism (-938C>A) is associated with adverse outcome in patients with prostate carcinomaIn: International Journal of Cancer, Jg. 129, 2011, Nr. 10, S. 2390 – 2399
-
Telomeres and prognosis in patients with chronic lymphocytic leukaemiaIn: International Journal of Hematology, Jg. 93, 2011, Nr. 1, S. 74 – 82
-
A variant allele of Growth Factor Independence 1 (GFI1) is associated with acute myeloid leukemiaIn: Blood, Jg. 115, 2010, Nr. 12, S. 2462 – 2472
-
Four routinely recorded parameters define four distinct prognostic groups in AMLIn: Journal of Clinical Oncology (JCO), Jg. 28, 2010, Nr. Suppl. 15, S. 6584
-
Gene dosage effects in chronic lymphocytic leukemiaIn: Cancer Genetics and Cytogenetics, Jg. 203, 2010, Nr. 2, S. 149 – 160
-
Mitoxantron-assoziierte akute Leukämie bei Multipler Sklerose : Fallbericht und praktisches Vorgehen bei unklaren ZytopenienIn: Der Nervenarzt, Jg. 81, 2010, Nr. 12, S. 1483 – 1489
-
Percentage of smudge cells determined on routine blood smears is a novel prognostic factor in chronic lymphocytic leukemiaIn: Leukemia Research, Jg. 34, 2010, Nr. 7, S. 892 – 898
-
Prognostic assessment of three single-nucleotide polymorphisms (GNB3 825C>T, BCL2-938C>A, MCL1-386C>G) in extrahepatic cholangiocarcinomaIn: Cancer Investigation, Jg. 28, 2010, Nr. 5, S. 472 – 478
-
The G-Allele of the PSMA6-8C>G polymorphism is associated with poor outcome in multiple myeloma independently of circulating proteasome serum levelsIn: European Journal of Haematology, Jg. 85, 2010, Nr. 2, S. 108 – 113
-
The prognostic significance of soluble NKG2D ligands in B-cell chronic lymphocytic leukemiaIn: Leukemia, Jg. 24, 2010, Nr. 6, S. 1152 – 1159
-
Association of the AA genotype of the BCL2 (-938C>A) promoter polymorphism with better survival in ovarian cancerIn: The International Journal of Biological Markers (IJBM), Jg. 24, 2009, Nr. 4, S. 223 – 229
-
BCL2-938C>A polymorphism and disease progression in chronic lymphocytic leukemiaIn: Leukemia and Lymphoma, Jg. 50, 2009, Nr. 11, S. 1837 – 1842
-
Combined PER2 and CRY1 expression predicts outcome in chronic lymphocytic leukemiaIn: European Journal of Haematology, Jg. 83, 2009, Nr. 4, S. 320 – 327
-
FCRL2 mRNA expression is inversely associated with clinical progression in chronic lymphocytic leukemiaIn: European Journal of Haematology, Jg. 83, 2009, Nr. 6, S. 541 – 549
-
The regulatory BCL2 promoter polymorphism (-938C>A) is associated with relapse and survival of patients with oropharyngeal squamous cell carcinomaIn: Annals of Oncology, Jg. 20, 2009, Nr. 6, S. 1094 – 1099DOI (Open Access)
-
Significantly shorter telomeres in T-cells of patients with ZAP-70+/CD38+ chronic lymphocytic leukaemiaIn: British Journal of Haematology, Jg. 143, 2008, Nr. 3, S. 383 – 386
-
Association of a novel regulatory polymorphism (-938C>A) in the BCL2 gene promoter with disease progression and survival in chronic lymphocytic leukemiaIn: Blood, Jg. 109, 2007, Nr. 1, S. 290 – 297
-
The AA genotype of the regulatory BCL2 promoter polymorphism (-938C>A) is associated with a favorable outcome in lymph node negative invasive breast cancer patientsIn: Clinical Cancer Research, Jg. 13, 2007, Nr. 19, S. 5790 – 5797DOI (Open Access)
-
Trisomy 19 is associated with trisomy 12 and mutated IGHV genes in B-chronic lymphocytic leukaemiaIn: British Journal of Haematology, Jg. 138, 2007, Nr. 2, S. 217 – 220
-
Bax gene G(-248)A promoter polymorphism and chronic lymphocytic leukemia: lack of association with incidence, disease stage and progression-free survivalIn: Leukemia, Jg. 20, 2006, Nr. 4, S. 724
-
Gene expression signatures separate B-cell chronic lymphocytic leukaemia prognostic subgroups defined by ZAP-70 and CD38 expression statusIn: Leukemia, Jg. 20, 2006, Nr. 10, S. 1774 – 1782
-
Lipoprotein lipase expression is a novel prognostic factor in B-cell chronic lymphocytic leukemiaIn: Leukemia & Lymphoma, Jg. 47, 2006, Nr. 6, S. 1053 – 1061
-
No association of the NFKB1 insertion/deletion promoter polymorphism with survival in colorectal and renal cell carcinoma as well as disease progression in B-cell chronic lymphocytic leukemiaIn: Pharmacogenetics and Genomics, Jg. 16, 2006, Nr. 11, S. 783 – 788
-
The GNAS1 T393C polymorphism is associated with disease progression and survival in chronic lymphocytic leukemiaIn: Clinical Cancer Research, Jg. 12, 2006, Nr. 19, S. 5686 – 5692
-
HLA-G expression is associated with an unfavorable outcome and immunodeficiency in chronic lymphocytic leukemiaIn: Blood, Jg. 105, 2005, Nr. 4, S. 1694 – 1698
-
Methylenetetrahydrofolate reductase (MTHFR) gene 677C>T and 1298A>C polymorphisms are associated with differential apoptosis of leukemic B cells in vitro and disease progression in chronic lymphocytic leukemiaIn: Leukemia, Jg. 18, 2004, Nr. 11, S. 1816 – 1823
-
Quantification of G protein Gαs subunit splice variants in different human tissues and cells using pyrosequencingIn: Gene Expression, Jg. 12, 2004, Nr. 2, S. 69 – 81DOI (Open Access)
-
Expression of ribosomal and translation-associated genes is correlated with a favorable clinical course in chronic lymphocytic leukemiaIn: Blood, Jg. 101, 2003, Nr. 7, S. 2748 – 2755
-
Salvage chemotherapy according to the ASHAP protocol : a single-center study of 24 patients with relapsed or refractory aggressive non-Hodgkin's lymphomasIn: Annals of Hematology, Jg. 82, 2003, Nr. 8, S. 481 – 486
-
The CC genotype of the C825T polymorphism of the G protein beta3 gene (GNB3) is associated with a high relapse rate in patients with chronic lymphocytic leukaemiaIn: Leukemia & Lymphoma, Jg. 44, 2003, Nr. 10, S. 1739 – 1743
-
ZAP-70 expression is a prognostic factor in chronic lymphocytic leukemiaIn: Leukemia, Jg. 17, 2003, Nr. 12, S. 2426 – 2434
-
Cardiac chloroma in a patient with relapsed acute myeloid leukemia
Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Onkologie. Basel, 30.09.–04.10. 2011,In: Onkologie. Basel: Karger, Jg. 34, 2011, Nr. Suppl. 6, S. 85 -
Percentage of smudge cells on routine blood smears predict time to first treatment and overall survival in patients with Binet stage A chronic lymphocytic leukemia
Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Onkologie. Basel, 30.09.–04.10. 2011,In: Onkologie. Basel: Karger, Jg. 34, 2011, Nr. Suppl. 6, S. 139 -
Association of HLA-G haplotype risk model with treatment free survival in chronic lymphocytic leukemia patients
Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Onkologie, Berlin, Oktober 2010,In: Onkologie. Basel: Karger, Jg. 33, 2010, Nr. Suppl. 6, S. 45 -
Case report : Excessive bilirubin elevation in a patient with hereditary spherocytosis and combined ABCB11 gene variants
Deutsche, Österreichische und Schweizerische Gesellschaften für Hämatologie und Onkologie Jahrestagung, Berlin, Oktober 2010,In: Onkologie. Basel: Karger, Jg. 33, 2010, Nr. Suppl. 6, S. 49 -
High soluble MICA levels are associated to MICA-129 val/val genotypes and poor treatment free survival in chronic lymphocytic leukemia
Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Onkologie. Berlin, 1.–5. Oktober 2010,In: Onkologie. Basel: Karger, Jg. 33, 2010, Nr. Suppl. 6, S. 41 – 42 -
Prognostic scoring system for multiple myeloma patients undergoing high-dose therapy with autologous stem cell transplantation
Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Onkologie. Berlin, 1.–5. Oktober 2010,In: Onkologie. Basel: Karger, Jg. 33, 2010, Nr. Suppl. 6, S. 250 -
ST-Elevated Myocardial Infarction in a Female Patient with Thiamin-Responsive Megaloblastic Anemia (TRMA) Presenting a Novel Mutation in Exon 4 of the SLC19A2 GeneIn: Circulation. Baltimore; New York, NY; Dallas: American Heart Association, Jg. 122, 2010, Nr. 2, S. P1487
-
Simple Methods for the Detection of HLA-G Variants in Coding and Non-coding RegionsIn: Immunogenetics: Methods and Applications in Clinical Practice / Christiansen, Frank T.; Tait, Brian D. (Hrsg.). New York: Humana Press, 2012, S. 123 – 142